Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases
Consensus endpoints were developed for invasive candidiasis, invasive aspergillosis, cryptococcosis, and mucormycosis for use in clinical trials.
Authors
- Neil M. Ampel (ORCID: https://orcid.org/0000-0003-2872-4396)
- Todd P McCarty
- Marisa H. Miceli (ORCID: https://orcid.org/0000-0002-3175-0512)
- Fariba M. Donovan
- George R Thompson III
- Alessandro C Pasqualotto
- Peter G Pappas
- Thomas J Walsh
- Luis Ostrosky-Zeichner
- Gerald McGwin
- Thuy Le
- David R Boulware
- Jose Portugal Gonzales
Institutions
- University of Maryland, Baltimore (US)
- University of Minnesota (US)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- University of Arizona (US)
- University of Valley Forge (US)
- University of Michigan (US)
- Santa Casa Hospital (BR)
- University of Alabama at Birmingham (US)
- Innovative Clinical Research (US)
- Duke University Health System (US)
- The University of Texas Health Science Center (US)
- University of California, Davis (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1093/ofid/ofag012
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00